News

11 de April de 1880

  • Kasznar Leonardos

Regulatory Law in the Health Area

Our Regulatory team anticipates and prepares your company with regard to the sector’s challenges and opportunities.

We act within the scope of competence of the rule-making entities towards the feasibility of commercialization of products and services, as well as the authorization of licensing of operations, including the approval of projects, registration of products and securing import licenses. We also participate most actively in workgroups, associations and events, in addition to monitoring all legislation updates.

We provide consultancy and litigation services and we act at all times of interaction with the health authorities, particularly the Brazilian Health Supervision Agency [ANVISA – Agência Nacional de Vigilância Sanitária] and the Brazilian Complementary Health [Private Health Insurance] Agency [ANS – Agência Nacional de Saúde Complementar].

Ours is a multidisciplinary approach, with actions carried out together with other fields – such as intellectual property, public law and anti-corruption practices, to better provide assistance to your business in strategic matters throughout the entire life cycle of your products, irrespective of the latter consisting in medicaments, biological products, medical devices, foodstuffs, cosmetic products, sanitation products or agrochemical products.

Back

Last related news

20 de August de 2026

Kasznar Leonardos Participates in the 46th ABPI Annual Conference on Innovation and Intellectual Property

Partners, attorneys, and interns from Kasznar Leonardos attended the 46th Annual ABPI Conference on Innovation and Intellectual Property 2026. The event took Kasznar Leonardos Participates in the 46th ABPI Annual Conference on Innovation and Intellectual Property

  • Kasznar Leonardos
  • Ler notícia

    19 de August de 2026

    Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System

    Brazil’s National Institute of Industrial Property (INPI) released its new Strategic Plan for 2027–2036 on August 14, 2026. The plan launches a Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System

    Ler notícia

    14 de August de 2026

    INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

    On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

    Ler notícia